Who
Rachel Ellingson
Director
Company insider
Files Form 4 as: Director, BioLife Solutions; Chief Administrative Officer, Zimmer Biomet Holdings; VP, Global Communications, St Jude Medical.
In numbers
- Trades disclosed
- 152
- Buys
- 0
- Sells
- 4
- Bought
- $0
- Sold
- $1.0M
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 30 Aug 2012
- Last trade
- 6 Oct 2026
- Last filed
- 8 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Oct 2026filed 8 Oct 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code D | —57,995 | filing |
| 24 Feb 2026filed 26 Feb 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code A | —8,170 | filing |
| 24 Feb 2026filed 26 Feb 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code A | —8,170 | filing |
| 18 Mar 2025filed 20 Mar 2025 | BioLife SolutionsMedical Devices | SEC FORM 4 Code A | —6,876 | filing |
| 20 Feb 2025filed 24 Feb 2025 | ZBH Zimmer Biomet Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code M | —1,566 at $0.00 | filing |
| 20 Feb 2025filed 24 Feb 2025 | ZBH Zimmer Biomet HoldingsMedical Devices | SEC FORM 4 Code M | —1,566 at $0.00 | filing |
| 20 Feb 2025filed 24 Feb 2025 | ZBH Zimmer Biomet HoldingsMedical Devices | SEC FORM 4 Code F | $51K491 at $103.46 | filing |
| 18 Feb 2025filed 19 Feb 2025 | ZBH Zimmer Biomet Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code M | —5,572 at $0.00 | filing |
| 18 Feb 2025filed 19 Feb 2025 | ZBH Zimmer Biomet HoldingsMedical Devices | SEC FORM 4 Code M | —5,572 at $0.00 | filing |
| 18 Feb 2025filed 19 Feb 2025 | ZBH Zimmer Biomet HoldingsMedical Devices | SEC FORM 4 Code F | $181K1,792 at $101.00 | filing |
| 14 Feb 2025filed 19 Feb 2025 | ZBH Zimmer Biomet Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code A | —5,572 at $0.00 | filing |
| 8 Mar 2024filed 12 Mar 2024 | BioLife SolutionsMedical Devices | SEC FORM 4 Code A | —11,264 | filing |
| 6 Mar 2024filed 8 Mar 2024 | ZBH Zimmer Biomet Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code M | —1,419 at $0.00 | filing |
| 6 Mar 2024filed 8 Mar 2024 | ZBH Zimmer Biomet HoldingsMedical Devices | SEC FORM 4 Code M | —1,419 at $0.00 | filing |
| 6 Mar 2024filed 8 Mar 2024 | ZBH Zimmer Biomet HoldingsMedical Devices | SEC FORM 4 Code F | $56K445 at $125.82 | filing |
| 25 Feb 2024filed 27 Feb 2024 | ZBH Zimmer Biomet Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code M | —1,762 at $0.00 | filing |
| 25 Feb 2024filed 27 Feb 2024 | ZBH Zimmer Biomet HoldingsMedical Devices | SEC FORM 4 Code M | —1,762 at $0.00 | filing |
| 25 Feb 2024filed 27 Feb 2024 | ZBH Zimmer Biomet HoldingsMedical Devices | SEC FORM 4 Code F | $76K588 at $128.80 | filing |
| 20 Feb 2024filed 22 Feb 2024 | ZBH Zimmer Biomet Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code A | —4,697 at $0.00 | filing |
| 1 Nov 2023filed 3 Nov 2023 | BioLife SolutionsMedical Devices | SEC FORM 4 Code A | —495 | filing |
News
No headline names them, or the companies they trade most, lately.